Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:110-115
Published online before print April 30, 2007, doi: 10.1161/HYPERTENSIONAHA.106.085761
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/1/110    most recent
HYPERTENSIONAHA.106.085761v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sivieri, D. O.
Right arrow Articles by Salgado, M. C. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sivieri, D. O., Jr
Right arrow Articles by Salgado, M. C. O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*3-MERCAPTOPROPIONIC ACID
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow ACE/Angiotension receptors

(Hypertension. 2007;50:110.)
© 2007 American Heart Association, Inc.


Original Articles

Potentiation of Bradykinin Effect by Angiotensin-Converting Enzyme Inhibition Does Not Correlate With Angiotensin-Converting Enzyme Activity in the Rat Mesenteric Arteries

Disney O. Sivieri, Jr; Luiz B. Bispo-da-Silva; Eduardo B. Oliveira; Angela C. Resende; Maria Cristina O. Salgado

From the Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.

Correspondence to Maria Cristina O. Salgado, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto-USP, 14049-900 Ribeirão Preto, São Paulo, Brazil. E-mail mcdosalg{at}fmrp.usp.br

Angiotensin-converting enzyme (kininase II [ACE]) inhibitors are capable of potentiating bradykinin (BK) effects by enhancing the actions of bradykinin on B2 receptors independent of blocking its inactivation. To investigate further the importance of ACE kininase activity on BK-induced vasodilation, we investigated the effect of inhibiting ACE, as well as other kininases, on both BK metabolism and vasodilator effect in preparations that exhibit increased ACE activity. Mesenteric arterial beds obtained from 1-kidney, 1-clip hypertensive rats presented augmented ACE and angiotensin I converting activities compared with normotensive rats. The isolated and perfused mesenteric beds were exposed to BK for 15 minutes in the absence or in the presence of kininase inhibitors; then, the perfusate was collected for analysis of the products of BK metabolism by high-performance liquid chromatography. BK was metabolized to the fragments BK(1-8), BK(1-7), and BK(1-5), and the recovery of intact BK was reduced by 47% in the hypertensive group. Recovery of BK was increased in both groups in the presence of a kininase I inhibitor and in the hypertensive group by neutral endopeptidase 24.11 inhibitor; however, ACE inhibition did not affect BK metabolism in both groups. In contrast, only the ACE inhibitor potentiated the vasodilator effect of BK in a mesenteric bed preconstricted with phenylephrine; the increase in BK effect, nevertheless, was not greater in arteries from hypertensive rats that presented an increased ACE activity when compared with those in the normotensive group. These data demonstrated that ACE inhibitor–induced potentiation of BK vasodilator effects is not related to their actions on BK degradation.


Key Words: bradykinin • ACE activity • kininase I • endopeptidases • ACE inhibitor




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Augustyniak, M. Maliszewska-Scislo, H. Chen, J. Fallucca, and N. F. Rossi
Acute angiotensin-converting enzyme inhibition evokes bradykinin-induced sympathetic activation in diabetic rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2260 - R2266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. B. Oliveira, L. L. Souza, D. O. Sivieri Jr, L. B. Bispo-da-Silva, H. J. V. Pereira, C. M. Costa-Neto, M. V. Sousa, and M. C. O. Salgado
Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3550 - H3557.
[Abstract] [Full Text] [PDF]